Cancer, Advanced Completed Phase 1 Trials for Rigosertib (DB12146)

Also known as: Advanced Cancer / Cancer / Neoplasm malignant / Malignant neoplasm NOS / Cancer NOS / Malignant tumor / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

IndicationStatusPhase
DBCOND0041606 (Cancer, Advanced)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01538537Safety of ON 01910.Na as a 3-day Infusion in Patients With Advanced CancerTreatment
NCT01538563Safety of 24-Hour Infusion of ON 01910.Na in Patients With Advanced CancerTreatment